Webster Bank’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $152K | Buy |
1,203
+17
| +1% | +$2.24K | 0.01% | 259 |
|
|
2026
Q1 | $165K | Buy |
1,186
+311
| +36% | +$43.6K | 0.02% | 250 |
|
|
2025
Q4 | $107K | Buy |
875
+89
| +11% | +$10.8K | 0.01% | 273 |
|
|
2025
Q3 | $87.2K | Hold |
786
| – | – | 0.01% | 296 |
|
|
2025
Q2 | $87.1K | Hold |
786
| – | – | 0.01% | 298 |
|
|
2025
Q1 | $88.1K | Sell |
786
-265
| -25% | -$27.3K | 0.01% | 292 |
|
|
2024
Q4 | $97.1K | Hold |
1,051
| – | – | 0.01% | 282 |
|
|
2024
Q3 | $88.1K | Hold |
1,051
| – | – | 0.01% | 298 |
|
|
2024
Q2 | $72.1K | Hold |
1,051
| – | – | 0.01% | 308 |
|
|
2024
Q1 | $77K | Hold |
1,051
| – | – | 0.01% | 298 |
|
|
2023
Q4 | $85.1K | Hold |
1,051
| – | – | 0.01% | 285 |
|
|
2023
Q3 | $78.8K | Hold |
1,051
| – | – | 0.01% | 269 |
|
|
2023
Q2 | $81K | Hold |
1,051
| – | – | 0.01% | 268 |
|
|
2023
Q1 | $87.2K | Buy |
1,051
+113
| +12% | +$9.36K | 0.01% | 277 |
|
|
2022
Q4 | $81K | Sell |
938
-200
| -18% | -$15.8K | 0.01% | 281 |
|
|
2022
Q3 | $70K | Hold |
1,138
| – | – | 0.01% | 282 |
|
|
2022
Q2 | $71K | Sell |
1,138
-50
| -4% | -$3.1K | 0.01% | 280 |
|
|
2022
Q1 | $71K | Hold |
1,188
| – | – | 0.01% | 293 |
|
|
2021
Q4 | $86K | Buy |
1,188
+580
| +95% | +$39.9K | 0.01% | 285 |
|
|
2021
Q3 | $43K | Sell |
608
-150
| -20% | -$10.5K | ﹤0.01% | 353 |
|
|
2021
Q2 | $52K | Hold |
758
| – | – | 0.01% | 329 |
|
|
2021
Q1 | $49K | Hold |
758
| – | – | 0.01% | 338 |
|
|
2020
Q4 | $44K | Hold |
758
| – | – | 0.01% | 337 |
|
|
2020
Q3 | $48K | Hold |
758
| – | – | 0.01% | 302 |
|
|
2020
Q2 | $58K | Hold |
758
| – | – | 0.01% | 284 |
|
|
2020
Q1 | $57K | Sell |
758
-100
| -12% | -$6.91K | 0.01% | 267 |
|
|
2019
Q4 | $56K | Sell |
858
-450
| -34% | -$29.3K | 0.01% | 309 |
|
|
2019
Q3 | $83K | Hold |
1,308
| – | – | 0.01% | 263 |
|
|
2019
Q2 | $88K | Buy |
1,308
+300
| +30% | +$19.7K | 0.01% | 253 |
|
|
2019
Q1 | $65K | Sell |
1,008
-210
| -17% | -$14K | 0.01% | 279 |
|
|
2018
Q4 | $76K | Hold |
1,218
| – | – | 0.01% | 252 |
|
|
2018
Q3 | $94K | Hold |
1,218
| – | – | 0.01% | 262 |
|
|
2018
Q2 | $87K | Sell |
1,218
-335
| -22% | -$23.7K | 0.01% | 271 |
|
|
2018
Q1 | $117K | Sell |
1,553
-1,375
| -47% | -$109K | 0.02% | 248 |
|
|
2017
Q4 | $210K | Buy |
2,928
+1,525
| +109% | +$116K | 0.03% | 207 |
|
|
2017
Q3 | $113K | Sell |
1,403
-249
| -15% | -$19K | 0.02% | 257 |
|
|
2017
Q2 | $117K | Sell |
1,652
-179
| -10% | -$11.9K | 0.02% | 256 |
|
|
2017
Q1 | $125K | Buy |
1,831
+624
| +52% | +$43.9K | 0.02% | 256 |
|
|
2016
Q4 | $86K | Buy |
+1,207
| New | +$89.7K | 0.01% | 286 |
|
|
2016
Q3 | – | Sell |
-23,651
| Closed | -$1.97M | – | 218 |
|
|
2016
Q2 | $1.97M | Sell |
23,651
-3,160
| -12% | -$280K | 0.29% | 77 |
|
|
2016
Q1 | $2.46M | Buy |
26,811
+1,707
| +7% | +$154K | 0.38% | 67 |
|
|
2015
Q4 | $2.54M | Buy |
25,104
+3,879
| +18% | +$404K | 0.41% | 68 |
|
|
2015
Q3 | $2.08M | Buy |
21,225
+2,324
| +12% | +$258K | 0.38% | 68 |
|
|
2015
Q2 | $2.21M | Buy |
+18,901
| New | +$2.07M | 0.37% | 68 |
|
|
2014
Q2 | – | Sell |
-4,609
| Closed | -$327K | – | 199 |
|
|
2014
Q1 | $327K | Buy |
4,609
+705
| +18% | +$55.3K | 0.05% | 166 |
|
|
2013
Q4 | $293K | Sell |
3,904
-105
| -3% | -$7.31K | 0.04% | 175 |
|
|
2013
Q3 | $252K | Hold |
4,009
| – | – | 0.04% | 176 |
|
|
2013
Q2 | $205K | Buy |
+4,009
| New | +$209K | 0.03% | 200 |
|
Other funds holding GILD
Webster Bank's GILD Position: Q2 2026 in Review
Webster Bank increased its Gilead Sciences (GILD) stake by 1.4% in Q2 2026, buying an estimated $2.24K and bringing the position to 1,203 shares worth $152K. The position accounts for 0.01% of the portfolio, ranked #259.
Webster Bank first reported a position in GILD in Q2 2013 and has held it in 48 quarters since. The position peaked at $2.54M in Q4 2015. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Webster Bank held 1,203 shares of Gilead Sciences worth $152K as of Q2 2026.
- Webster Bank bought 17 Gilead Sciences shares in Q2 2026, an estimated $2.24K.
- Gilead Sciences made up 0.01% of Webster Bank's portfolio in Q2 2026, its #259 holding.
- Webster Bank first reported a position in Gilead Sciences in Q2 2013 and has held it in 48 quarters since.
- Webster Bank's Gilead Sciences position peaked at $2.54M in Q4 2015.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Webster Bank's 13F filing for Q2 2026, filed 20 Jul 2026.